Keiko Hosohata

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Topics

Emergency Department

Oral Anticoagulants

Acute Kidney Injury

Top Venues

International journal of molecular sciences

Infection and drug resistance

Therapeutics and clinical risk management

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuhiro Furumachi, Tatsuki Kagatsume, Akari Higuchi, Mariko Kozaru, Etsuko Kumagai, Keiko Hosohata
Association Between COVID-19 and Diabetes Management Indices in Japanese Type 2 Diabetes Mellitus Patients: A Single-Center, Retrospective Study. Infection and drug resistance 17 (2024)
Mariko Kozaru, Hiroko Kambara, Akari Higuchi, Tatsuki Kagatsume, Keiko Hosohata
Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database. Vascular health and risk management 20 (2024)
Akie Yoshida, Kazuhiro Furumachi, Etsuko Kumagai, Keiko Hosohata
Risk Factors for COVID-19 Infection in Adult Patients: A Retrospective Observational Study in Japan. Infection and drug resistance 17 (2024)
Akie Yoshida, Kazuhiro Furumachi, Etsuko Kumagai, Keiko Hosohata
Risk Factors for COVID-19 Infection in Adult Patients: A Retrospective Observational Study in Japan. Infection and drug resistance 17 (2024)
Etsuko Kumagai, Kazuhiro Furumachi, Akihiro Kurihara, Ken Hosokawa, Keiko Hosohata, Shinji Takai
Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial. International journal of nephrology 2023 (2023)
Mariko Kozaru, Tatsuya Iida, Keiko Hosohata
A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Keiko Hosohata, Tanisorn Harnsirikarn, Susama Chokesuwattanaskul
Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury. International journal of molecular sciences 23 (12) (2022)
Takeo Hata, Atsushi Hirata, Ryosuke Ota, Keiko Hosohata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database. Therapeutics and clinical risk management 18 (2022)
Etsuko Kumagai, Keiko Hosohata, Kazuhiro Furumachi, Shinji Takai
Range of serum transthyretin levels in hemodialysis patients at a high risk of 1-year mortality: A retrospective cohort study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2021)
Tomohito Wakabayashi, Keiko Hosohata, Saki Oyama, Ayaka Inada, Iku Niinomi, Hiroko Kambara, Tatsuya Iida, Keiko Hasebe, Hiroyuki Matsuoka, Mayako Uchida, Etsuko Kumagai
Association between a low dose of proton pump inhibitors and kidney function decline in elderly hypertensive patients: a retrospective observational study. The Journal of international medical research 49 (4) (2021)
Keiko Hosohata, Denan Jin, Shinji Takai
Glaucocalyxin A Ameliorates Hypoxia/Reoxygenation-Induced Injury in Human Renal Proximal Tubular Epithelial Cell Line HK-2 Cells. International journal of molecular sciences 23 (1) (2021)
Keiko Hosohata, Hiroyuki Matsuoka, Etsuko Kumagai
Association of urinary vanin-1 with kidney function decline in hypertensive patients. Journal of clinical hypertension (Greenwich, Conn.) 23 (7) (2021)
Keiko Hosohata, Denan Jin, Shinji Takai
In Vivo and In Vitro Evaluation of Urinary Biomarkers in Ischemia/Reperfusion-Induced Kidney Injury. International journal of molecular sciences 22 (21) (2021)
Tomohito Wakabayashi, Keiko Hosohata, Saki Oyama, Ayaka Inada, Sayaka Ueno, Hiroko Kambara, Tatsuya Iida, Takahiro Nakatsuji, Mayako Uchida, Kazunori Iwanaga
Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database. Therapeutics and clinical risk management 16 (2020)
Keiko Hosohata, Ayaka Inada, Saki Oyama, Takashi Doi, Iku Niinomi, Tomohito Wakabayashi, Mayako Uchida, Kazunori Iwanaga, Hiroyuki Matsuoka
Improvement of Blood Pressure Control by Adherence Check in Patients With Apparent Treatment-Resistant Hypertension: A Case Series. Clinical medicine insights. Case reports 13 (2020)
Satoshi Washino, Keiko Hosohata, Tomoaki Miyagawa
Roles Played by Biomarkers of Kidney Injury in Patients with Upper Urinary Tract Obstruction. International journal of molecular sciences 21 (15) (2020)
Keiko Hosohata, Nathan Mise, Fujio Kayama, Kazunori Iwanaga
Augmentation of cadmium-induced oxidative cytotoxicity by pioglitazone in renal tubular epithelial cells. Toxicology and industrial health 35 (8) (2020)
Keiko Hosohata, Hiroyuki Matsuoka, Kazunori Iwanaga, Etsuko Kumagai
Urinary vanin-1 associated with chronic kidney disease in hypertensive patients: A pilot study. Journal of clinical hypertension (Greenwich, Conn.) 22 (8) (2020)
Iku Niinomi, Keiko Hosohata, Saki Oyama, Ayaka Inada, Tomohito Wakabayashi, Kazunori Iwanaga
Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database. International journal of toxicology 38 (6) (2019)
Keiko Hosohata, Ayaka Inada, Saki Oyama, Iku Niinomi, Tomohito Wakabayashi, Kazunori Iwanaga
Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database. Clinical drug investigation 39 (4) (2019)
Satoshi Washino, Keiko Hosohata, Masashi Oshima, Tomohisa Okochi, Tsuzumi Konishi, Yuhki Nakamura, Kimitoshi Saito, Tomoaki Miyagawa
A Novel Biomarker for Acute Kidney Injury, Vanin-1, for Obstructive Nephropathy: A Prospective Cohort Pilot Study. International journal of molecular sciences 20 (4) (2019)
Ayaka Inada, Saki Oyama, Iku Niinomi, Tomohito Wakabayashi, Kazunori Iwanaga, Keiko Hosohata
Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: Subgroup analysis based on a Japanese spontaneous database. Journal of clinical pharmacy and therapeutics 44 (5) (2019)
Keiko Hosohata, Denan Jin, Shinji Takai, Kazunori Iwanaga
Involvement of Vanin-1 in Ameliorating Effect of Oxidative Renal Tubular Injury in Dahl-Salt Sensitive Rats. International journal of molecular sciences 20 (18) (2019)
Keiko Hosohata, Saki Oyama, Iku Niinomi, Tomohito Wakabayashi, Ayaka Inada, Kazunori Iwanaga
Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database. Clinical drug investigation 39 (7) (2019)
Mayako Uchida, Yuki Kondo, Shinya Suzuki, Keiko Hosohata
Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database. The Annals of pharmacotherapy 53 (12) (2019)
Keiko Hosohata, Denan Jin, Shinji Takai, Kazunori Iwanaga
Vanin-1 in Renal Pelvic Urine Reflects Kidney Injury in a Rat Model of Hydronephrosis. International journal of molecular sciences 19 (10) (2018)
Keiko Hosohata, Ayaka Inada, Saki Oyama, Daisuke Furushima, Hiroshi Yamada, Kazunori Iwanaga
Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach. Journal of clinical pharmacy and therapeutics 44 (1) (2018)
Keiko Hosohata
Biomarkers for Chronic Kidney Disease Associated with High Salt Intake. International journal of molecular sciences 18 (10) (2017)
Satoshi Washino, Keiko Hosohata, Denan Jin, Shinji Takai, Tomoaki Miyagawa
Early urinary biomarkers of renal tubular damage by a high-salt intake independent of blood pressure in normotensive rats. Clinical and experimental pharmacology & physiology 45 (3) (2017)